Tag Archives: Into

Pfizer Japan drawn into valsartan recall after finding API from Mylan is tainted

The global recall of valsartan has now extended to Pfizer and to Japan, via Mylan and India. According to a translated copy of its announcement, Pfizer’s Tokyo-based Japanese subsidiary said it is recalling from the country five lots of its blood pressure combo drug Amubaro because its API contains impurities that are probable carcinogens. The recall began… Read More »

The development of brain stem cells into new nerve cells and why this can lead to cancer

Ana Martin-Villalba and her research team at the German Cancer Research Center followed stem cells along the path to neurons. The scientists analyzed at every step which genes where switched on and which of them were actually turned into new proteins. They expected to find that stem cells would simply switch their stem cell genes… Read More »

Narrative Medicine Mondays program introduces storytelling into health fields – Duke Chronicle

Photo by Sujal Manohar | The Chronicle Narrative Medicine Mondays, a monthly lunch group, invites participants to analyze media and write stories around a certain theme. With a Top 10 medical school and substantial pre-health advising office, Duke certainly has a stake in the field of medicine. A new program hopes to bring other disciplines… Read More »